The RECK gene was isolated by an expression cloning strategy designed to isolate human cDNAs inducing flat reversion in a v-Ki-ras-transformed NIH3T3 cell line (Noda et al., 1989; Kitayama et al., 1989; Takahashi et al., 1996) . The RECK-encoded glycoprotein (molecular weight 110,000) contains serine protease inhibitor-like domains and is associated with the cell membrane through a carboxy-terminal glycosylphosphatidylinositol (GPI)-modification (Takahashi et al., 1998) . While the RECK gene is widely expressed in various human organs, its expression is low or undetectable in many tumor-derived cell lines; also, RECK expression can be downregulated by several oncogenes, including ras (Takahashi et al., 1998; Sasahara et al., 1999). When RECK gene expression was artificially restored in several tumor-derived cell lines, the amount of extracellular pro-MMP-9 produced by these cells was reduced, and their invasive and metastatic potentials were suppressed (Takahashi et al., 1998), suggesting a role for RECK in the regulation of MMP-9 and tumor malignancy.
In the present study, we further evaluated the biochemical activities of RECK and explored its biological functions in vivo through gene targeting experiments as well as tumor transplantation experiments in mice. The results indicate that RECK negatively regulates two other MMPs, MMP-2 and MT1-MMP, and document the importance of RECK in the regulation of ECM remodeling and blood vessel formation.
Results

Downregulation of Active MMP-2 by RECK
Since RECK was originally identified as a membraneassociated negative regulator of MMP-9 (Takahashi et al., 1998), we used the human fibrosarcoma-derived cell line HT1080, which expresses both MMP-2 and MMP-9 but does not express RECK, to determine if RECK might also regulate MMP-2. When conditioned medium from HT1080 cells transfected with a control vector was ana- lyzed by gelatin zymography, we could detect four major is formed on the cell surface, and the pro-MMP-2 is cleaved at a specific site (Asn
37
-Leu 38 in the human probands: the 92 kilodalton (kDa) band corresponding to the molecular weight (MW) of pro-MMP-9, and a triplet tein) by a second MT1-MMP molecule to yield the intermediate form of MMP-2. Second, the removal of the of bands around 70 kDa corresponding (from top to bottom) to the MW of the pro-, intermediate, and active residual prodomain is achieved through intermolecular, autoproteolytic cleavage, and is accompanied by reforms of MMP-2 ( Figure 1A , lane 2). When RECK was expressed in these cells, the amount of secreted prolease of active MMP-2 from the membrane. Thus, a simple mechanism which would explain the observed MMP-9 and active MMP-2 were significantly reduced ( Figure 1A, lane 3) . A less drastic, but reproducible, redownregulation of active MMP-2 would be the upregulation of TIMP-2, since TIMP-2 is known to inhibit MT1-duction in the amount of the intermediate form of MMP-2 was also noted. Immunoblot assays, however, indicated MMP as well as active MMP-2 in vitro. RECK does not, however, alter the level of TIMP-2 mRNA ( Figure 1B ). that RECK did not affect the total amount of MMP-2 protein associated with the cells (Figure 1C ). InterestDownregulation of MT1-MMP expression could also explain our finding; however, the level of MT1-MMP exingly, we previously showed that the amount of MMP-9 mRNA expressed by HT1080 cells is not affected by pression was not reduced by RECK (Figures 1B and 1C) . We therefore tested the possibility of direct enzymatic RECK expression (Takahashi et al., 1998) . Thus, RECK regulates MMP-2 and MMP-9 posttranscriptionally.
inhibition of MT1-MMP activity using purified recombinant proteins. In this assay, we employed a soluble MT1-MMP protein (MT1-F; Kinoshita et al., 1998) anchoring allows RECK to be concentrated on the plasma membrane (unpublished data) and to effectively cally reduced in RECK-deficient mouse embryos (Figures 3E and 3J) (Gomi et al., 1995) . Chimeric HT1080 cells transfected with empty pCXN2 or pCXN2 containing males, identified by coat color, were bred to C57BL/6J and 129/Sv hRECK cDNA were trypsinized, suspended at 5 ϫ 10 7 /ml in PBS females.
containing antibiotics, and inoculated subcutaneously into the back Generation, genotyping, and characterization of MMP-2-deficient of 4 week old female Balb/c nu/nu mice (0.2 ml per site/animal; n ϭ mice have been described (Itoh et al., 1997) . The RECK ϩ/Ϫ mice 10). Sizes (length, width, and height) of the tumors were measured were first backcrossed into the C57BL/6 strain five generation and weekly, and three animals were sacrificed at appropriate time points then intercrossed with the MMP-2 Ϫ/Ϫ mice to generate MMP-2 ϩ/Ϫ for histological examination. Survival of the remaining 7 animals was RECK ϩ/Ϫ mice. These double heterozygotes were crossed to obtain monitored 2-3 times a week. The experiments using mice were MMP-2 Ϫ/Ϫ RECK ϩ/Ϫ mice which were then crossed each other to carried out following institutional guidelines. Measurements on miobtain MMP2 Ϫ/Ϫ RECK Ϫ/Ϫ embryos. croscopic images were carried out using the software NIH Image. 
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